- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 2.98K sh |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 53 sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | 22.96M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | 4.62M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | 9.17M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | 3.11M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −4.98M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | 4.39M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | 4.55M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | 34.83M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | 919.96K |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | 852.09K |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | 53.5M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | 25.85M |
| Current Assets | Q1 2025 · Mar 31, 2025 | 23.25M |
| Current Assets | Q1 2025 · Dec 31, 2024 | 4.97M |
| Total Assets | Q1 2025 · Mar 31, 2025 | 48.52M |
| Total Assets | Q1 2025 · Dec 31, 2024 | 30.24M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −3,586.00 |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −574,515.00 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −3,586.00 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −574,515.00 |
| Rd Expense | Q1 2025 · Mar 31, 2025 | 844.77K |
| Rd Expense | Q1 2025 · Mar 31, 2024 | 441.4K |
| Net Income | Q1 2025 · Mar 31, 2025 | −10.68M |
| Net Income | Q1 2025 · Mar 31, 2024 | −30.62M |
| Gross Profit | Q1 2025 · Mar 31, 2025 | 14.99K |
| Gross Profit | Q1 2025 · Mar 31, 2024 | 65.95K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | 187.71K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | 243.02K |
| Revenue | Q1 2025 · Mar 31, 2025 | 202.69K |
| Revenue | Q1 2025 · Mar 31, 2024 | 308.97K |